Fred Hutchinson Cancer — Seattle, Washington

Fred Hutchinson Cancer is a clinical research site located in Seattle, Washington, United States 98109-1023.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Fred Hutchinson Cancer has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fred Hutchinson Cancer?

Fred Hutchinson Cancer has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fred Hutchinson Cancer conducted?

Fred Hutchinson Cancer has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell.

Is Fred Hutchinson Cancer accredited by Crixeo Health?

Fred Hutchinson Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fred Hutchinson Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.